These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
667 related items for PubMed ID: 27092808
21. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity. Rovner E, Dmochowski R, Chapple C, Thompson C, Lam W, Haag-Molkenteller C. Neurourol Urodyn; 2013 Nov; 32(8):1109-15. PubMed ID: 23389824 [Abstract] [Full Text] [Related]
23. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. Palleschi G, Pastore AL, Stocchi F, Bova G, Inghilleri M, Sigala S, Carbone A. Clin Neuropharmacol; 2006 Nov; 29(4):220-9. PubMed ID: 16855424 [Abstract] [Full Text] [Related]
24. OAB score: a clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study. Arribillaga LC, Ledesma M, Montedoro A, Pisano F, Bengió RG. Int Braz J Urol; 2018 Nov; 44(2):348-354. PubMed ID: 29211399 [Abstract] [Full Text] [Related]
25. Are patients with the symptoms of overactive bladder and urodynamic detrusor overactivity different from those with overactive bladder but not detrusor overactivity? Fan YH, Lin CC, Lin AT, Chen KK. J Chin Med Assoc; 2011 Oct; 74(10):455-9. PubMed ID: 22036137 [Abstract] [Full Text] [Related]
26. [The influence of mesh pelvic floor reconstructive surgery on OAB symptoms]. Nowakowski L, Wróbel A, Jankiewicz K, Kulik-Rechberger B, Rechberger T. Ginekol Pol; 2014 Oct; 85(10):760-4. PubMed ID: 25546927 [Abstract] [Full Text] [Related]
27. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters. Humblet M, Verpoorten C, Christiaens MH, Hirche H, Jansen K, Buyse G, van Gool JD. Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114 [Abstract] [Full Text] [Related]
28. Overactive bladder syndrome: what is the role of evidence of detrusor overactivity in the cystometric study? Vecchioli-Scaldazza C, Grinta R. Minerva Urol Nefrol; 2010 Dec; 62(4):355-61. PubMed ID: 20944536 [Abstract] [Full Text] [Related]
29. Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence. Panayi DC, Duckett J, Digesu GA, Camarata M, Basu M, Khullar V. Neurourol Urodyn; 2009 Dec; 28(1):82-5. PubMed ID: 19089898 [Abstract] [Full Text] [Related]
30. Is Detrusor Contraction during Rapid Bladder Filling Caused by Cold or Warm Water? A Randomized, Controlled, Double-Blind Trial. Kozomara M, Mehnert U, Seifert B, Kessler TM. J Urol; 2018 Jan; 199(1):223-228. PubMed ID: 28751267 [Abstract] [Full Text] [Related]
31. Urodynamic assessment of bladder and urethral function among men with lower urinary tract symptoms after radical prostatectomy: A comparison between men with and without urinary incontinence. Lee H, Kim KB, Lee S, Lee SW, Kim M, Cho SY, Oh SJ, Jeong SJ. Korean J Urol; 2015 Dec; 56(12):803-10. PubMed ID: 26682020 [Abstract] [Full Text] [Related]
32. Comparison of urodynamic results and quality of life between women with interstitial cystitis and overactive bladder. Hsu CC, Liang CC, Chang SD, Chien CW, Hsieh WC. Taiwan J Obstet Gynecol; 2020 Jan; 59(1):39-42. PubMed ID: 32039798 [Abstract] [Full Text] [Related]
33. Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport® (abobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor overactivity (NDO): A randomised placebo-controlled phase IIa study. Denys P, Del Popolo G, Amarenco G, Karsenty G, Le Berre P, Padrazzi B, Picaut P, Dysport Study Group. Neurourol Urodyn; 2017 Feb; 36(2):457-462. PubMed ID: 26756554 [Abstract] [Full Text] [Related]
34. In women with urinary incontinence how necessary is cystometry? Saleem A. J Pak Med Assoc; 2010 May; 60(5):356-9. PubMed ID: 20527606 [Abstract] [Full Text] [Related]
35. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity. Shahab N, Seki N, Takahashi R, Kajioka S, Takei M, Yamaguchi A, Naito S. Neurourol Urodyn; 2009 May; 28(8):953-8. PubMed ID: 19260093 [Abstract] [Full Text] [Related]
36. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, Amarenco G, Gamé X, Kirby R, Van Der Aa F, Cornu JN. Eur Urol; 2019 Jun; 75(6):988-1000. PubMed ID: 30922690 [Abstract] [Full Text] [Related]
37. The long-term natural history of overactive bladder symptoms due to idiopathic detrusor overactivity in women. Garnett S, Swithinbank L, Ellis-Jones J, Abrams P. BJU Int; 2009 Oct; 104(7):948-53. PubMed ID: 19389015 [Abstract] [Full Text] [Related]
38. Observations relating to urinary sensation during detrusor overactivity. Lowenstein L, Pham T, Abbasy S, Kenton K, Brubaker L, Mueller ER, Shott S, Vardi Y, Gruenwald I, FitzGerald MP. Neurourol Urodyn; 2009 Oct; 28(6):497-500. PubMed ID: 19090593 [Abstract] [Full Text] [Related]
39. Urodynamic study in the neurogenic bladder dysfunction caused by intervertebral disk hernia. Dong D, Xu Z, Shi B, Chen J, Jiang X, Wang H. Neurourol Urodyn; 2006 Oct; 25(5):446-50. PubMed ID: 16847921 [Abstract] [Full Text] [Related]
40. Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder. Haab F. Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S2-5. PubMed ID: 25042138 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]